Volagidemab
id:
volagidemab-306-15829751
title:
Volagidemab
text:
Volagidemab is a monoclonal antibody that targets the glucagon receptor. It is developed by REMD Biotherapeutics for type 1 and type 2 diabetes. A phase II trial did not meet its primary endpoint.
brand slug:
wiki
category slug:
encyclopedia
description:
Monoclonal antibody
original url:
https://en.wikipedia.org/wiki/Volagidemab
date created:
date modified:
2024-03-08T14:12:01Z
main entity:
{"identifier":"Q123857875","url":"https://www.wikidata.org/entity/Q123857875"}
image:
fields total:
13
integrity:
14